BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Billerbeck E, Böttler T, Thimme R. Regulatory T cells in viral hepatitis. World J Gastroenterol 2007; 13(36): 4858-4864 [PMID: 17828817 DOI: 10.3748/wjg.v13.i36.4858]
URL: https://www.wjgnet.com/1007-9327/full/v13/i36/4858.htm
Number Citing Articles
1
Ji Yoon Bae, Hyung Kyung Kim, Hanna Kang, Ha Rin Cheong, Dong Eun Song, Sun Hee Sung, Heasoo Koo, Woon Sup Han, Jeong Kyong Lee, Tae-Hun Kim, Kyu Won Chung, Min-Sun Cho. Frequency of Intrahepatic FoxP3+ Regulatory T cells during the Natural Course of Chronic Hepatitis B: An Immunohistochemical Study Using Needle-Biopsied Liver TissueThe Korean Journal of Pathology 2010; 44(2): 132 doi: 10.4132/KoreanJPathol.2010.44.2.132
2
Damião C. M. dos Santos, Patricia C. C. Neves, Elzinandes L. Azeredo, Marcelo Pelajo-Machado, José Manoel S. G. Martinho, Lúcio F. Pacheco-Moreira, Cristina C. V. Araújo, Oswaldo Gonçalves Cruz, Jaqueline Mendes Oliveira, Marcelo Alves Pinto. Activated lymphocytes and high liver expression of IFN-γ are associated with fulminant hepatic failure in patientsLiver International 2012; 32(1): 147 doi: 10.1111/j.1478-3231.2011.02654.x
3
Wei Li, Jun Han, Hong Wu. Regulatory T-cells promote hepatitis B virus infection and hepatocellular carcinoma progressionChronic Diseases and Translational Medicine 2016; 2(2): 67 doi: 10.1016/j.cdtm.2016.09.001
4
Yasuteru Kondo, Masashi Ninomiya, Eiji Kakazu, Osamu Kimura, Tooru Shimosegawa. Hepatitis B Surface Antigen Could Contribute to the Immunopathogenesis of Hepatitis B Virus InfectionISRN Gastroenterology 2013; 2013: 1 doi: 10.1155/2013/935295
5
Robert Thimme, Salim I. Khakoo. Viral Hepatitis2013; : 266 doi: 10.1002/9781118637272.ch18
6
ZEHUI YAN, JIJUN ZHOU, MENGJUN ZHANG, XIAOLAN FU, YUZHANG WU, YUMING WANG. Telbivudine decreases proportion of peripheral blood CD4+CD25+CD127low T cells in parallel with inhibiting hepatitis B virus DNAMolecular Medicine Reports 2014; 9(5): 2024 doi: 10.3892/mmr.2014.2042
7
Albert S. Reece. Chronic viral hepatitis is a significant contributor to the immunosenescent phenotype of parenteral drug addictionAddiction Biology 2009; 14(2): 214 doi: 10.1111/j.1369-1600.2008.00123.x
8
A. Boasso, G. M. Shearer, C. Chougnet. Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?Journal of Internal Medicine 2009; 265(1): 78 doi: 10.1111/j.1365-2796.2008.02043.x
9
Tamara Severi, Hannah van Malenstein, Chris Verslype, Jos F van Pelt. Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targetsActa Pharmacologica Sinica 2010; 31(11): 1409 doi: 10.1038/aps.2010.142
10
Shaoyong Li, Lianne E.M. Vriend, Imad A. Nasser, Yury Popov, Nezam H. Afdhal, Margaret J. Koziel, Detlef Schuppan, Mark A. Exley, Nadia Alatrakchi. Hepatitis c virus-specific t-cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesisHepatology 2012; 56(6): 2094 doi: 10.1002/hep.25951
11
Inbal Houri, Oren Shibolet. Hepatocellular Carcinoma2016; : 243 doi: 10.1007/978-3-319-34214-6_16
12
Di Wu, Qin Ning. Hepatitis B Virus and Liver Disease2018; : 219 doi: 10.1007/978-981-10-4843-2_12
13
Linlin Wang, Xiaocen Wang, Lin Tong, Jian Wang, Maosen Dou, Shimeng Ji, Jing Bi, Cuicui Chen, Dong Yang, Hong He, Chunxue Bai, Jian Zhou, Yuanlin Song. Recovery from acute lung injury can be regulated via modulation of regulatory T cells and Th17 cellsScandinavian Journal of Immunology 2018; 88(5): e12715 doi: 10.1111/sji.12715
14
Paul Shapshak, Charurut Somboonwit, Lydia N. Drumright, Simon D.W. Frost, Deborah Commins, Timothy L. Tellinghuisen, William K. Scott, Robert Duncan, Clyde McCoy, J. Bryan Page, Brian Giunta, Francisco Fernandez, Elyse Singer, Andrew Levine, Alireza Minagar, Oluwadayo Oluwadara, Taiwo Kotila, Francesco Chiappelli, John T. Sinnott. Molecular and Contextual Markers of Hepatitis C Virus and Drug AbuseMolecular Diagnosis & Therapy 2009; 13(3): 153 doi: 10.1007/BF03256323
15
Xiaojing Wang, Weiming Yan, Yulei Lu, Tao Chen, Ying Sun, Xiaomin Qin, Jiangguo Zhang, Meifang Han, Wei Guo, Hongwu Wang, Di Wu, Dong Xi, Xiaoping Luo, Qin Ning. CD4–CD8-T cells contribute to the persistence of viral hepatitis by striking a delicate balance in immune modulationCellular Immunology 2012; 280(1): 76 doi: 10.1016/j.cellimm.2012.11.010
16
Yanfang Jiang, Wanyu Li, Lei Yu, Jingjing Liu, Guijie Xin, Hongqing Yan, Pinghui Sun, Hong Zhang, Damo Xu, Junqi Niu. Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapiesCellular & Molecular Immunology 2011; 8(1): 75 doi: 10.1038/cmi.2010.37
17
Hoda Mohamed El-Emshaty, Wesam Ahmad Nasif, Ibrahim Eldsoky Mohamed. Serum Cytokine of IL-10 and IL-12 in Chronic Liver Disease: The Immune and Inflammatory ResponseDisease Markers 2015; 2015: 1 doi: 10.1155/2015/707254
18
Robert Thimme, Maura Dandri. Dissecting the divergent effects of interferon-alpha on immune cells: Time to rethink combination therapy in chronic hepatitis B?Journal of Hepatology 2013; 58(2): 205 doi: 10.1016/j.jhep.2012.11.007
19
Cecilia G. Giadans, Daniela A. Ríos, Beatriz Ameigeiras, Adriana M. Pietrantonio, Néstor L. Lucatelli, Leila Haddad, Eduardo Mullen, Fabiana Heinrich, Elena De Matteo, Diego Flichman, Pamela Valva, María V. Preciado. Chronic hepatitis B: The interplay between intrahepatic lymphocyte population and viral antigens in relation to liver damageJournal of Viral Hepatitis 2019; 26(6): 727 doi: 10.1111/jvh.13078
20
Leonn Mendes Soares Pereira, Samara Tatielle Monteiro Gomes, Ricardo Ishak, Antonio Carlos Rosário Vallinoto. Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune HomeostasisFrontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00605
21
Rosanna Villani, Gianluigi Vendemiale, Gaetano Serviddio. Molecular Mechanisms Involved in HCC Recurrence after Direct-Acting Antiviral TherapyInternational Journal of Molecular Sciences 2018; 20(1): 49 doi: 10.3390/ijms20010049
22
E. Loffredo-Verde, I. Abdel-Aziz, J. Albrecht, N. El-Guindy, M. Yacob, A. Solieman, U. Protzer, D. H. Busch, L. E. Layland, C. U. Prazeres da Costa. Schistosome infection aggravates HCV-related liver disease and induces changes in the regulatory T-cell phenotypeParasite Immunology 2015; 37(2): 97 doi: 10.1111/pim.12171
23
Nora A. Fierro, Flor P. Castro-Garcia, Arturo Panduro. Rethinking cytokine function during hepatitis A and hepatitis C infectionsAdvances in Bioscience and Biotechnology 2013; 4(07): 13 doi: 10.4236/abb.2013.47A1003
24
Thomas F Baumert, Eloi R Verrier, Michael Nassal, Raymond T Chung, Mirjam B Zeisel. Host-targeting agents for treatment of hepatitis B virus infectionCurrent Opinion in Virology 2015; 14: 41 doi: 10.1016/j.coviro.2015.07.009
25
Mark A. Feitelson, Alla Arzumanyan, Helena M. G. P. V. Reis, Marcia M. Clayton, Bill S. Sun, Zhaorui Lian. Molecular Pathology of Liver DiseasesMolecular Pathology Library 2011; 5: 553 doi: 10.1007/978-1-4419-7107-4_37
26
Luca G Guidotti, Masanori Isogawa, Francis V Chisari. Host–virus interactions in hepatitis B virus infectionCurrent Opinion in Immunology 2015; 36: 61 doi: 10.1016/j.coi.2015.06.016
27
Ahmad Karkhah, Mostafa Javanian, Soheil Ebrahimpour. The role of regulatory T cells in immunopathogenesis and immunotherapy of viral infectionsInfection, Genetics and Evolution 2018; 59: 32 doi: 10.1016/j.meegid.2018.01.015
28
Leonhard Stross, Johannes Günther, Georg Gasteiger, Theresa Asen, Stefanie Graf, Michaela Aichler, Irene Esposito, Dirk H. Busch, Percy Knolle, Tim Sparwasser, Ulrike Protzer. Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in miceHepatology 2012; 56(3): 873 doi: 10.1002/hep.25765
29
Julia Schmidt, Hubert E Blum, Robert Thimme. T-cell responses in hepatitis B and C virus infection: similarities and differencesEmerging Microbes & Infections 2013; 2(1): 1 doi: 10.1038/emi.2013.14
30
Marc Ringelhan, Tracy O'Connor, Ulrike Protzer, Mathias Heikenwalder. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targetsThe Journal of Pathology 2015; 235(2): 355 doi: 10.1002/path.4434
31
Seyed Hossein Aalaei-Andabili, Seyed Moayed Alavian. Regulatory T cells are the most important determinant factor of hepatitis B infection prognosis: A systematic review and meta-analysisVaccine 2012; 30(38): 5595 doi: 10.1016/j.vaccine.2012.06.063
32
Polyxeni P. Doumba, Elisavet Serti, Maria Boutsikou, Manousos M. Konstadoulakis, Urania Georgopoulou, John Koskinas. Phenotypic and functional alterations of primary human PBMCs induced by HCV non-enveloped capsid-like particles uptakeCellular and Molecular Life Sciences 2013; 70(18): 3463 doi: 10.1007/s00018-013-1344-y
33
Vitaly Ablamunits, Octavian Henegariu, Paula Preston-Hurlburt, Kevan C. Herold. NKG2A is a marker for acquisition of regulatory function by human CD8+T cells activated with anti-CD3 antibodyEuropean Journal of Immunology 2011; 41(7): 1832 doi: 10.1002/eji.201041258
34
Di Wu, Qin Ning. Hepatitis B Virus and Liver Disease2021; : 319 doi: 10.1007/978-981-16-3615-8_14
35
Margarita Dominguez-Villar, Cecilia Fernandez-Ponce, Alba Munoz-Suano, Esperanza Gomez, Manuel Rodríguez-Iglesias, Francisco Garcia-Cozar. Up-regulation of FOXP3 and induction of suppressive function in CD4+ Jurkat T-cells expressing hepatitis C virus core proteinClinical Science 2012; 123(1): 15 doi: 10.1042/CS20110631
36
Carolina Boni, Harry L.A. Janssen, Marzia Rossi, Seung Kew Yoon, Andrea Vecchi, Valeria Barili, Eric M. Yoshida, Huy Trinh, Timothy C. Rodell, Diletta Laccabue, Arianna Alfieri, Federica Brillo, Paola Fisicaro, Greta Acerbi, Giuseppe Pedrazzi, Pietro Andreone, Carmela Cursaro, Marzia Margotti, Rosanna Santoro, Valeria Piazzolla, Maurizia R. Brunetto, Barbara Coco, Daniela Cavallone, Yang Zhao, Adarsh Joshi, Jacky Woo, Audrey H. Lau, Anuj Gaggar, G. Mani Subramanian, Benedetta Massetto, Scott Fung, Sang Hoon Ahn, Xiaoli Ma, Alessandra Mangia, Carlo Ferrari. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic HepatitisGastroenterology 2019; 157(1): 227 doi: 10.1053/j.gastro.2019.03.044
37
Leonn M. S. Pereira, Ednelza da Silva Graça Amoras, Simone R. S. da Silva Conde, Sâmia Demachki, Jaqueline C. Monteiro, Rosimar N. Martins-Feitosa, Andrea N. M. R. da Silva, Ricardo Ishak, Antonio C. R. Vallinoto. The −3279C>A and −924A>G polymorphisms in the FOXP3 Gene Are Associated With Viral Load and Liver Enzyme Levels in Patients With Chronic Viral Liver DiseasesFrontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02014
38
S. Ramachandran, D. S. Campo, Z. E. Dimitrova, G.-l. Xia, M. A. Purdy, Y. E. Khudyakov. Temporal Variations in the Hepatitis C Virus Intrahost Population during Chronic InfectionJournal of Virology 2011; 85(13): 6369 doi: 10.1128/JVI.02204-10
39
Shishir Shetty, David H Adams, Stefan G Hubscher. Post-transplant liver biopsy and the immune response: lessons for the clinicianExpert Review of Clinical Immunology 2012; 8(7): 645 doi: 10.1586/eci.12.65
40
Ji Hye Hwang, Hyo Won Jung. Effects of the Pharmacopuncture with MOK on Immune Regulation by Th1/Th2 Cytokines in L-Thyroxine-Induced Hyperthyroid RatsKorean Journal of Acupuncture 2018; 35(2): 91 doi: 10.14406/acu.2018.010
41
Richard C. Duke, Alex Franzusoff, David Apelian. Chronic Viral Hepatitis2009; : 471 doi: 10.1007/978-1-59745-565-7_19
42
Palma A. Iacovazzi, Raffaele Cozzolongo, Elsa Lanzillotta, Stefania Frisullo, Vito Guerra, Mario Correale. Serum 90K/Mac-2 Binding Protein (Mac-2BP) as a Response Predictor to Peginterferon and Ribavirin Combined Treatment in Hcv Chronic PatientsImmunopharmacology and Immunotoxicology 2008; 30(4): 687 doi: 10.1080/08923970802278177
43
Ming-Hsiang Hong, Yu-Chi Chou, Yi-Chieh Wu, Kuen-Nan Tsai, Cheng-po Hu, King-Song Jeng, Mong-Liang Chen, Chungming Chang, Wang-Shick Ryu. Transforming Growth Factor-β1 Suppresses Hepatitis B Virus Replication by the Reduction of Hepatocyte Nuclear Factor-4α ExpressionPLoS ONE 2012; 7(1): e30360 doi: 10.1371/journal.pone.0030360
44
Yuming Yu, Joshua Miller, Joseph R. Leventhal, Anat R. Tambur, Dhivya Chandrasekaran, Josh Levitsky, Xunrong Luo, James M. Mathew, Philip J. Norris. Requirement of Cognate CD4+ T-Cell Recognition for the Regulation of Allospecific CTL by Human CD4+CD127−CD25+FOXP3+ Cells Generated in MLRPLoS ONE 2011; 6(7): e22450 doi: 10.1371/journal.pone.0022450
45
Di Wu, Qin Ning. Toward a Cure for Hepatitis B Virus Infection: Combination Therapy Involving Viral Suppression and Immune Modulation and Long-term OutcomeThe Journal of Infectious Diseases 2017; 216(suppl_8): S771 doi: 10.1093/infdis/jix355
46
S.M. Criscione. May viral (antigen) load be the real crucial tool leading to anergy in a “micro-evolutionary” model of host/virus interaction?Medical Hypotheses 2012; 79(6): 774 doi: 10.1016/j.mehy.2012.08.026
47
Shuo Li, Stefan Floess, Alf Hamann, Silvana Gaudieri, Andrew Lucas, Margaret Hellard, Stuart Roberts, Geza Paukovic, Magdalena Plebanski, Bruce E. Loveland, Campbell Aitken, Simon Barry, Louis Schofield, Eric J. Gowans, Wherry E. John. Analysis of FOXP3+ Regulatory T Cells That Display Apparent Viral Antigen Specificity during Chronic Hepatitis C Virus InfectionPLoS Pathogens 2009; 5(12): e1000707 doi: 10.1371/journal.ppat.1000707
48
Hyosun Cho. The Roles of Immune Regulatory Factors FoxP3, PD-1, and CTLA-4 in Chronic Viral InfectionThe Korean Journal of Microbiology 2013; 49(3): 221 doi: 10.7845/kjm.2013.3049
49
Nadia Alatrakchi, Margaret Koziel. Regulatory T cells and viral liver diseaseJournal of Viral Hepatitis 2009; 16(4): 223 doi: 10.1111/j.1365-2893.2009.01081.x
50
W. Halota, P. Ferenci, D. Kozielewicz, D. Dybowska, N. Lisovoder, S. Samira, I. Shalit, R. Ellis, Y. Ilan. Oral anti-CD3 immunotherapy for HCV-nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase-2a placebo-controlled trialJournal of Viral Hepatitis 2015; 22(8): 651 doi: 10.1111/jvh.12369
51
Adam J. Gehring. New treatments to reach functional cure: Rationale and challenges for emerging immune-based therapiesBest Practice & Research Clinical Gastroenterology 2017; 31(3): 337 doi: 10.1016/j.bpg.2017.05.004